Castle Biosciences Inc (CSTL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.01B
Last updated: Nov 17, 2026 at 4:15 PM ET
Castle Biosciences Inc (CSTL) Stock Chart
Castle Biosciences (CSTL) has a latest price of $32.98 on Nov 17, 2026, 25.5% below its 52-week high of $44.28. Its price fell 1.4% over the past 12 months. The month-end price fell 40.4% over the 5 years through Oct 2026, a compound annual decline of 9.8%.
Price Chart
From Jul 2019 to Oct 2026, its highest month-end close was $76.73 in Aug 2021 and its lowest $13.72 in Jun 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CSTL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CSTL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 2.0%, and over 6 months it rose 71.8%. The month-end price rose 137.9% over the 3 years through Oct 2026, a compound annual rate of 33.5%.
| Period | Change |
|---|---|
| 1 month | +2.5% |
| 3 months | +2.0% |
| 6 months | +71.8% |
| 12 months | -1.4% |
| 12 months, with dividends | -1.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +137.9% | +33.5% |
| 5 years | -40.4% | -9.8% |
Price by Year
Its best calendar year was 2020, when the price rose 95.4%, and its weakest was 2022, when it fell 45.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $37.16 | -4.5% |
| 2025 | $38.90 | +46.0% |
| 2024 | $26.65 | +23.5% |
| 2023 | $21.58 | -8.3% |
| 2022 | $23.54 | -45.1% |
| 2021 | $42.87 | -36.2% |
| 2020 | $67.15 | +95.4% |
Trading Range
The price is 4.0% below its 50-day average of $34.35 and 17.3% above its 200-day average of $28.12.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $32.98 | |
| 52-week high | $44.28 | -25.5% |
| 52-week low | $17.72 | +86.1% |
| 50-day average | $34.35 | -4.0% |
| 200-day average | $28.12 | +17.3% |
Price Risk
Over 3 years, its largest fall from a peak was 57.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.12 |
| Largest fall, 1 year | -57.8% |
| Largest fall, 3 years | -57.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CSTL
What is CSTL's 1-year price change?
Castle Biosciences's price fell 1.4% over the past 12 months. With dividends included, the 12-month total return was -1.4%.
What is CSTL's 5-year price change?
Castle Biosciences's month-end price fell 40.4% over the 5 years through Oct 2026, a compound annual decline of 9.8%. These figures leave out dividends.
What is CSTL's 52-week high and low?
Castle Biosciences's 52-week high is $44.28 and its 52-week low is $17.72. Its latest price of $32.98 on Nov 17, 2026 is 25.5% below the high.
What is CSTL's beta?
Castle Biosciences's 1-year beta against the S&P 500 is 1.12, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 57.8%.
Is the CSTL chart free?
Yes. Advanced Charting for CSTL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CSTL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts